{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:17:54Z","timestamp":1793395074949,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T00:00:00Z","timestamp":1383609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-9966-32-87","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T16:39:52Z","timestamp":1383669592000},"source":"Crossref","is-referenced-by-count":73,"title":["Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer"],"prefix":"10.1186","volume":"32","author":[{"given":"Francesca","family":"Suriano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Onetti","family":"Muda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,5]]},"reference":[{"key":"722_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010, 46: 765-781. 10.1016\/j.ejca.2009.12.014.","journal-title":"Eur J Cancer"},{"key":"722_CR2","volume-title":"AJCC cancer staging manual","author":"JD Fleming","year":"1997","unstructured":"Fleming JD, Cooper JS, Jenson DE, et al: AJCC cancer staging manual. 1997, 5","edition":"5"},{"issue":"3","key":"722_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables:a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006, 49 (3): 465-466.","journal-title":"Eur Urol"},{"key":"722_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0094-0143(05)70240-8","volume":"1","author":"JLF Duque","year":"2000","unstructured":"Duque JLF, Loughlin KR: An overview of the treatment of superficial bladder cancer. Urol Clin North AM. 2000, 1: 125-135.","journal-title":"Urol Clin North AM"},{"key":"722_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1756-9966-27-78","volume":"27","author":"DC Chade","year":"2008","unstructured":"Chade DC, Borra RC, Nascimento IP, Andrade PM, et al: Immunomodulatory effects of recombinant BCG ex pressing pertossi toxin on TNF-alfa and IL-10 in a bladder cancer model. J Exp Clin Cancer Res. 2008, 27: 78-10.1186\/1756-9966-27-78.","journal-title":"J Exp Clin Cancer Res"},{"key":"722_CR6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"2","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW: Intracavitary bacillus calmette guerin in the treatment of superficial bladder tumors. J Urol. 1976, 2: 180-183.","journal-title":"J Urol"},{"issue":"6","key":"722_CR7","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.eururo.2009.01.040","volume":"55","author":"C Ayary","year":"2009","unstructured":"Ayary C, LaRue H, Hovington H, Decobert M, Fradet Y, et al: Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus calmette guerin immunotherapy. Eur Urol. 2009, 55 (6): 1386-1396. 10.1016\/j.eururo.2009.01.040.","journal-title":"Eur Urol"},{"issue":"3","key":"722_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle L, Brown NJ, Lewis CE: The role of tumor associated macrophages in tumor progression: implications for new anticarncer terapie. J Pathol. 2002, 196 (3): 254-265. 10.1002\/path.1027.","journal-title":"J Pathol"},{"key":"722_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","volume":"17","author":"P Andreu","year":"2010","unstructured":"Andreu P, et al: FcRy activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell. 2010, 17: 121-134. 10.1016\/j.ccr.2009.12.019.","journal-title":"Cancer Cell"},{"key":"722_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","volume":"7","author":"KE De Visser","year":"2005","unstructured":"De Visser KE, Korets LV, Coussens LM: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell. 2005, 7: 411-423. 10.1016\/j.ccr.2005.04.014.","journal-title":"Cancer Cell"},{"key":"722_CR11","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.2741\/2944","volume":"13","author":"A Nardin","year":"2008","unstructured":"Nardin A, Abastado JP: Macrophages and cancer. Front Biosci. 2008, 13: 3494-3505.","journal-title":"Front Biosci"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.2278","volume":"17","author":"XD Yang","year":"2011","unstructured":"Yang XD, et al: Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b\u2009+\u2009Ly6G\u2009+\u2009immature myeloid cells. Nature Med. 2011, 17: 87-95. 10.1038\/nm.2278.","journal-title":"Nature Med"},{"key":"722_CR13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1084\/jem.20072602","volume":"205","author":"JR Sierra","year":"2008","unstructured":"Sierra JR, et al: Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med. 2008, 205: 1673-1685. 10.1084\/jem.20072602.","journal-title":"J Exp Med"},{"key":"722_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","volume":"7","author":"T Hanada","year":"2000","unstructured":"Hanada T, Nakagawa M, Emoto A, et al: Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol. 2000, 7: 263-269. 10.1046\/j.1442-2042.2000.00190.x.","journal-title":"Int J Urol"},{"key":"722_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1756-9966-32-5","volume":"32","author":"F Wei","year":"2013","unstructured":"Wei F, Wang H, Huang Q, et al: Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12. J Exp Clin Cancer Res. 2013, 32: 5-10.1186\/1756-9966-32-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"722_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.molimm.2011.04.022","volume":"48","author":"M Dufresne","year":"2008","unstructured":"Dufresne M, Dumas G, Asselin E, et al: Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma. Mol Immunol. 2008, 48: 1556-1567.","journal-title":"Mol Immunol"},{"issue":"6","key":"722_CR17","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1172\/JCI37869","volume":"119","author":"L Song","year":"2009","unstructured":"Song L, Asgharzadeh S, Salo J, et al: Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest. 2009, 119 (6): 1524-1536. 10.1172\/JCI37869.","journal-title":"J Clin Invest"},{"issue":"20","key":"722_CR18","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1200\/JCO.2008.19.9919","volume":"27","author":"TO Jensen","year":"2009","unstructured":"Jensen TO, Schmidt H, Moller HJ, et al: Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I\/II melanoma. J Clin Oncol. 2009, 27 (20): 3330-3337. 10.1200\/JCO.2008.19.9919.","journal-title":"J Clin Oncol"},{"issue":"2","key":"722_CR19","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","volume":"167","author":"H Kurahara","year":"2011","unstructured":"Kurahara H, Shinchi H, Mataki Y, et al: Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011, 167 (2): e211-e219. 10.1016\/j.jss.2009.05.026.","journal-title":"J Surg Res"},{"issue":"35","key":"722_CR20","doi-asserted-by":"publisher","first-page":"8959","DOI":"10.1200\/JCO.2005.01.4910","volume":"23","author":"TJ Welsh","year":"2005","unstructured":"Welsh TJ, Green RH, Richardson D, et al: Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small cell lung cancer. J Clin Oncol. 2005, 23 (35): 8959-8967. 10.1200\/JCO.2005.01.4910.","journal-title":"J Clin Oncol"},{"key":"722_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1756-9966-30-62","volume":"30","author":"R Wang","year":"2011","unstructured":"Wang R, Lu M, Zhang J, Chen H, et al: Increased IL-10 mRNA expression in tumor associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res. 2011, 30: 62-10.1186\/1756-9966-30-62.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"722_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1600-0463.2003.apm1111210.x","volume":"111","author":"A Puhakka","year":"2003","unstructured":"Puhakka A, Kinnula V, Napankangas U, et al: High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS. 2003, 111 (12): 1137-1146. 10.1111\/j.1600-0463.2003.apm1111210.x.","journal-title":"APMIS"},{"issue":"2","key":"722_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<276::AID-CNCR11>3.0.CO;2-Q","volume":"83","author":"TA Tran","year":"1998","unstructured":"Tran TA, Kallakury BV, Ambros RA, et al: Prognostic significante of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer. 1998, 83 (2): 276-282. 10.1002\/(SICI)1097-0142(19980715)83:2<276::AID-CNCR11>3.0.CO;2-Q.","journal-title":"Cancer"},{"issue":"3 Pt 1","key":"722_CR24","first-page":"G592","volume":"275","author":"DG Binion","year":"1998","unstructured":"Binion DG, Fu S, Ramanujam KS, et al: iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol. 1998, 275 (3 Pt 1): G592-G603.","journal-title":"Am J Physiol"},{"issue":"2","key":"722_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/01.ATV.18.2.157","volume":"18","author":"JS Luoma","year":"1998","unstructured":"Luoma JS, Stralin P, Marklund SL, et al: Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitome characteristics of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998, 18 (2): 157-167. 10.1161\/01.ATV.18.2.157.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"722_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006, 355 (1): 11-20. 10.1056\/NEJMoa055531.","journal-title":"N Engl J Med"},{"issue":"9007","key":"722_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(96)90144-0","volume":"347","author":"A Cuschieri","year":"1996","unstructured":"Cuschieri A, Fayers P, Fielding J, The Surgical Cooperative Group, et al: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet. 1996, 347 (9007): 995-999. 10.1016\/S0140-6736(96)90144-0.","journal-title":"Lancet"},{"issue":"1B","key":"722_CR28","first-page":"463","volume":"25","author":"S Ohno","year":"2005","unstructured":"Ohno S, Inagawa H, Dhar DK, et al: Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the Impact on FasL-mediated counterattack. Anticancer Res. 2005, 25 (1B): 463-470.","journal-title":"Anticancer Res"},{"key":"722_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/07853890410033171","volume":"36","author":"SK Moestrup","year":"2004","unstructured":"Moestrup SK, Moller HJ: CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med. 2004, 36: 347-354. 10.1080\/07853890410033171.","journal-title":"Ann Med"},{"key":"722_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","volume":"175","author":"RD Stout","year":"2005","unstructured":"Stout RD, Jiang C, Matta B, et al: Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005, 175: 342-349.","journal-title":"J Immunol"},{"issue":"4A","key":"722_CR31","first-page":"2609","volume":"21","author":"PG Foukas","year":"2001","unstructured":"Foukas PG, Tsilivakos V, Zacharatos P, et al: Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small cell lung carcinomas: a putative mechanism of tumor-induced immunosuppression?. Anticancer Res. 2001, 21 (4A): 2609-2615.","journal-title":"Anticancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-32-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-32-87\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-32-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:38:39Z","timestamp":1548232719000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-32-87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-32-87","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,5]]},"article-number":"87"}}